This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bartsch, O. Articles by Ivell, R. Search for Related Content PubMed PubMed Citation Articles by Bartsch, O. Articles by Ivell, R.

Phosphodiesterase 4 Inhibition Synergizes with Relaxin Signaling to Promote Decidualization of Human Endometrial Stromal Cells

Institute for Hormone and Fertility Research, University of Hamburg, 20251 Hamburg, Germany

Address all correspondence and requests for reprints to: Dr. Olaf Bartsch, Institute for Hormone and Fertility Research, University of Hamburg, Falkenried 88, 20251 Hamburg, Germany. E-mail: bartsch{at}ihf.de.

The decidualization of endometrial stromal cells in the secretory phase of the menstrual cycle is an essential prerequisite for the implantation of a blastocyst. This profound differentiation process is accompanied by sustained elevated intracellular cAMP concentrations in vivo. Primary cell cultures of endometrial stromal cells decidualize by treatment with cAMP-elevating agents in vitro. Our previous findings indicated that the cAMP-degrading activities of phosphodiesterases (PDE) and signaling of the peptide hormone relaxin are coupled in human endometrial stromal cells. In the present study we have chosen a pharmacological approach to test whether relaxin binding and PDE inhibition cooperate to induce decidualization. Measurement of PDE activity and relaxin-stimulated cAMP accumulation in the presence of diverse PDE inhibitors identified PDE4 and PDE8 as the principal PDE isoforms involved in human endometrial stromal cells. The PDE4 inhibitor rolipram was most effective in elevating intracellular cAMP concentrations and synergizing with relaxin to achieve maximal in vitro decidualization, as determined by measurement of the expression of the decidual marker genes for prolactin and IGF-binding protein-1 and measurement of prolactin secretion. Gene expression for PDE4D and PDE4C was significantly up-regulated during in vitro decidualization. Treatment of cell cultures with the protein kinase A inhibitor H89 revealed a minor role for protein kinase A-mediated positive feedback control of PDE4 activity in human endometrial stromal cells, consistent with sustained elevated cAMP essential for decidualization in vitro. These findings introduce the new idea of clinically applying the combination of a specific PDE4 inhibitor with an effector such as relaxin, thereby offering an alternative nonsteroidal luteal phase support for the endometrium to encourage endometrial development and implantation in subfertile women undergoing assisted reproductive technology procedures.

This work was supported by the Deutsche Forschungsgemeinschaft (Grant Iv7/9-1) and in part by the Leidenberger-Müller-Stiftung (Hamburg, Germany).

Abbreviations: 8Br-cAMP, 8-Bromo-cAMP; DMSO, dimethylsulfoxide; EHNA, erythro-9(2-hydroxy-3-nonyl)adenine; E-PBS, Eagle’s PBS buffer; ESC, endometrial stromal cell; FIA, fluorometric immunoassay; GAPD, glyceraldehyde-3-phosphate dehydrogenase; hPRL, human PRL; IBMX, 3-isobutyl-1-methylxanthine; IGF-BP1, IGF-binding protein-1; PDE, phosphodiesterase; PKA, protein kinase A; PRL, prolactin.

This article has been cited by other articles:

				R. Anand-Ivell, K. Heng, B. Hafen, B. Setchell, and R. Ivell Dynamics of INSL3 Peptide Expression in the Rodent Testis Biol Reprod, September 1, 2009; 81(3): 480 - 487. [Abstract] [Full Text] [PDF]

				M. Sasseville, F. K. Albuz, N. Cote, C. Guillemette, R. B. Gilchrist, and F. J. Richard Characterization of Novel Phosphodiesterases in the Bovine Ovarian Follicle Biol Reprod, August 1, 2009; 81(2): 415 - 425. [Abstract] [Full Text] [PDF]

				K. Heng, R. Ivell, P. Wagaarachchi, and R. Anand-Ivell Relaxin signalling in primary cultures of human myometrial cells Mol. Hum. Reprod., October 1, 2008; 14(10): 603 - 611. [Abstract] [Full Text] [PDF]

				W. Yan, J. Chen, A. A Wiley, B. D Crean-Harris, F. F Bartol, and C. A Bagnell Relaxin (RLX) and estrogen affect estrogen receptor {alpha}, vascular endothelial growth factor, and RLX receptor expression in the neonatal porcine uterus and cervix Reproduction, May 1, 2008; 135(5): 705 - 712. [Abstract] [Full Text] [PDF]

				A. Kern, D. Hubbard, A. Amano, and G. D. Bryant-Greenwood Cloning, Expression, and Functional Characterization of Relaxin Receptor (Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 7) Splice Variants from Human Fetal Membranes Endocrinology, March 1, 2008; 149(3): 1277 - 1294. [Abstract] [Full Text] [PDF]

				O.P.M. Smith, H.N. Jabbour, and H.O.D. Critchley Cyclooxygenase enzyme expression and E series prostaglandin receptor signalling are enhanced in heavy menstruation Hum. Reprod., May 1, 2007; 22(5): 1450 - 1456. [Abstract] [Full Text] [PDF]

				T. Kajihara, M. Jones, L. Fusi, M. Takano, F. Feroze-Zaidi, G. Pirianov, H. Mehmet, O. Ishihara, J. M. Higham, E. W.-F. Lam, et al. Differential Expression of FOXO1 and FOXO3a Confers Resistance to Oxidative Cell Death upon Endometrial Decidualization Mol. Endocrinol., October 1, 2006; 20(10): 2444 - 2455. [Abstract] [Full Text] [PDF]

				S. Hombach-Klonisch, J. Bialek, B. Trojanowicz, E. Weber, H.-J. Holzhausen, J. D. Silvertown, A. J. Summerlee, H. Dralle, C. Hoang-Vu, and T. Klonisch Relaxin Enhances the Oncogenic Potential of Human Thyroid Carcinoma Cells Am. J. Pathol., August 1, 2006; 169(2): 617 - 632. [Abstract] [Full Text] [PDF]

				J. Francis, R. Rai, N. J. Sebire, S. El-Gaddal, M. S. Fernandes, P. Jindal, A. Lokugamage, L. Regan, and J. J. Brosens Impaired expression of endometrial differentiation markers and complement regulatory proteins in patients with recurrent pregnancy loss associated with antiphospholipid syndrome Mol. Hum. Reprod., July 1, 2006; 12(7): 435 - 442. [Abstract] [Full Text] [PDF]

				R. A. Bathgate, R. Ivell, B. M. Sanborn, O. D. Sherwood, and R. J. Summers International Union of Pharmacology LVII: Recommendations for the Nomenclature of Receptors for Relaxin Family Peptides. Pharmacol. Rev., March 1, 2006; 58(1): 7 - 31. [Abstract] [Full Text] [PDF]

				C. S. Samuel Relaxin: Antifibrotic Properties and Effects in Models of Disease Clin. Med. Res., November 1, 2005; 3(4): 241 - 249. [Abstract] [Full Text] [PDF]

				E. Dimitriadis, C. Stoikos, M. Baca, W. D. Fairlie, J. E. McCoubrie, and L. A. Salamonsen Relaxin and Prostaglandin E2 Regulate Interleukin 11 during Human Endometrial Stromal Cell Decidualization J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3458 - 3465. [Abstract] [Full Text] [PDF]

				M. Tang, J. Mazella, H. Hui Zhu, and L. Tseng Ligand activated relaxin receptor increases the transcription of IGFBP-1 and prolactin in human decidual and endometrial stromal cells Mol. Hum. Reprod., April 1, 2005; 11(4): 237 - 243. [Abstract] [Full Text] [PDF]